Location: Home
  • search
  • go
  • Relate News
  • 10/26/2021Merck unveils first innovation collaboration site open to startups
  • 10/26/2021How China Turned the Tables on Biopharma's Global Dealmaking: Endpoint
  • 10/26/2021Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818
  • 10/25/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (51...
  • 10/25/2021111, Inc. and Chugai Pharma Enter Strategic Partnership With to Acce...
  • 10/25/2021CANbridge Enters Global Licensing Pact with Scriptr Global to Develop...
  • 10/25/2021Novartis's NDA for Ribociclib Accepted in China
  • 10/25/2021IQVIA Unveils Comprehensive Analysis of Chinese Retail Pharmacy Market
  • 10/22/2021Antengene to Join Hands with LegoChem Biosciences for Research of New...
  • 10/22/2021NeoCura and MDimune Settle CDVs-mediated mRNA Collaboration
  • 10/22/2021I-Mab Opens New R&D Lab in San Diego
  • 10/22/2021China's MOFCOM Pledges Foreign Investment Expansion as It Plans to Ste...
  • 10/22/2021Recent Executive Moves
  • 10/22/2021SCMP: U.S. Warns American Firms to Protect Five Key Technologies
  • 10/22/2021Reuters: EU Plans Stricter Drugs Supply Rules to Avoid Reliance on 'Au...
  • 10/21/2021NMPA Issues the List of Reference Formulations for GQCE Studies (46th ...
  • 10/21/2021NMPA Issues the List of Reference Formulations for GQCE Studies (47th ...
  • 10/21/2021Luoxin Enters Licensing Deal With Austria-Based Marinomed Biotech for ...
  • 10/21/2021Ligand and CR Double-Crane Enter Deal to Develop an Oral COVID-19 Ther...
  • 10/20/2021CStone Received Chinese IND Acceptance of lorlatinib for ROS1-posit...
  • 10/20/2021OliX, Pharmaron Agree to Advance Non-clinical Toxicology Testing for ...
  • 10/20/2021LianBio to Raise up to $345M in Planned IPO at Valuation of $1.8B
  • 10/20/2021COVID-19 Spurs Growth of China's Domestic Bioprocessing Suppliers: Bio...
  • 10/19/2021Chipscreen Secures Chinese Approval of Bilessglu (Chiglitazar Sodium t...
  • 10/19/2021Israel's Silenseed Inks $7.8M Deal with GIBF to Create Chinese JV
  • 10/19/2021Bridge Biotherapeutics Initiates Phase I Trial for Anti-inflammatory...
  • 10/19/2021Zai Lab and Entasis Announce Positive Topline Results for Sulbactam-Du...
  • 10/18/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline Q13
  • 10/18/2021NHC Issues the 14th FYP for National Clinical Specialty Capacity Build...
  • 10/18/2021WuXi ATU Opens Fourth Manufacturing Facility
  • Page:109/719 Total number of articles:21546: [First][<<] [107] [108] [109] [110] [111] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group